aeris Capital Equity Investments, L.P. - Net Worth and Insider Trading
aeris Capital Equity Investments, L.P. Net Worth
The estimated net worth of aeris Capital Equity Investments, L.P. is at least $14 Million dollars as of 2024-09-23. aeris Capital Equity Investments, L.P. is the 10% Owner of Adamas Pharmaceuticals Inc and owns about 1,662,128 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $14 Million. Details can be seen in aeris Capital Equity Investments, L.P.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that aeris Capital Equity Investments, L.P. has not made any transactions after 2015-03-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of aeris Capital Equity Investments, L.P.
aeris Capital Equity Investments, L.P. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, aeris Capital Equity Investments, L.P. owns 1 companies in total, including Adamas Pharmaceuticals Inc (ADMS) .
Insider Ownership Summary of aeris Capital Equity Investments, L.P.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADMS | Adamas Pharmaceuticals Inc | 2015-03-13 | 10 percent owner |
aeris Capital Equity Investments, L.P. Latest Holdings Summary
aeris Capital Equity Investments, L.P. currently owns a total of 1 stock. aeris Capital Equity Investments, L.P. owns 1,662,128 shares of Adamas Pharmaceuticals Inc (ADMS) as of March 13, 2015, with a value of $14 Million.
Latest Holdings of aeris Capital Equity Investments, L.P.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADMS | Adamas Pharmaceuticals Inc | 2015-03-13 | 1,662,128 | 8.22 | 13,662,692 |
Holding Weightings of aeris Capital Equity Investments, L.P.
aeris Capital Equity Investments, L.P. Form 4 Trading Tracker
According to the SEC Form 4 filings, aeris Capital Equity Investments, L.P. has made a total of 0 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 350,000 shares on March 13, 2015, which brought aeris Capital Equity Investments, L.P. around $6 Million.
Insider Trading History of aeris Capital Equity Investments, L.P.
- 1
aeris Capital Equity Investments, L.P. Trading Performance
aeris Capital Equity Investments, L.P. Ownership Network
aeris Capital Equity Investments, L.P. Owned Company Details
What does Adamas Pharmaceuticals Inc do?
Who are the key executives at Adamas Pharmaceuticals Inc?
aeris Capital Equity Investments, L.P. is the 10 percent owner of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .
Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adamas Pharmaceuticals Inc Insider Transactions
aeris Capital Equity Investments, L.P. Mailing Address
Above is the net worth, insider trading, and ownership report for aeris Capital Equity Investments, L.P.. You might contact aeris Capital Equity Investments, L.P. via mailing address: C/o Avalon Management Ltd, Landmark Sq 1st Floor, P.o. Box 715, 64 Earth Close Grand Cayman E9 Ky1-1107.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
